Literature DB >> 33844702

Correction: Site-specific analysis of N-glycans from different sheep prion strains.

Natali Nakić, Thanh Hoa Tran, Mislav Novokmet, Olivier Andreoletti, Gordan Lauc, Giuseppe Legname.   

Abstract

[This corrects the article DOI: 10.1371/journal.ppat.1009232.].

Entities:  

Year:  2021        PMID: 33844702      PMCID: PMC8041177          DOI: 10.1371/journal.ppat.1009511

Source DB:  PubMed          Journal:  PLoS Pathog        ISSN: 1553-7366            Impact factor:   6.823


There are glycopeptide structures missing in both Fig 2 and Fig 6. Please see the correct Fig 2 and Fig 6 here.
Fig 2

Detected N-184 glycopeptides on both prion strains.

Proposed glycan structures found on N-184 glycosylation site with the theoretical and observed m/z values of the detected glycopeptides. H–hexose, N–N-acetylhexosamine, F–fucose and S–N-acetylneuraminic acid (sialic acid). Blue square–N-acetylglucosamine (GlcNAc), green circle–mannose (Man), red triangle–fucose (Fuc), yellow circle–galactose (Gal), purple diamond–N-acetylneuraminic acid (Neu5Ac). The presence of MS/MS spectrum is indicated with +. N/D–not determined.

Fig 6

Identified N-200 glycopeptides on both prion strains.

Proposed glycan structures found on N-200 glycosylation site with the theoretical and observed m/z values of the detected glycopeptides. H–hexose, N–N-acetylhexosamine, F–fucose and S–N-acetylneuraminic acid (sialic acid). Blue square–N-acetylglucosamine (GlcNAc), green circle–mannose (Man), red triangle–fucose (Fuc), yellow circle–galactose (Gal), purple diamond–N-acetylneuraminic acid (Neu5Ac). The presence of MS/MS spectrum is indicated with +. N/D–not determined.

Also, in Fig 7 the m/z value 1255.8162 is associated with the wrong glycan composition and should be assigned to H5N6S1F2. Please see the correct Fig 7 here.
Fig 7

Representation of detected glycoforms on the N-200 glycosylation site of 21K slow prion strain.

A) Extracted ion chromatograms with mutual 35 glycoforms detected. B) Assigned glycoforms in MS spectrum with N-200 peptide backbone: neutral and monosialylated, C) disialylated and trisialylated glycoforms. Blue square–N-acetylglucosamine (GlcNAc), green circle–mannose (Man), red triangle–fucose (Fuc), yellow circle–galactose (Gal), purple diamond–N-acetylneuraminic acid (Neu5Ac).

Detected N-184 glycopeptides on both prion strains.

Proposed glycan structures found on N-184 glycosylation site with the theoretical and observed m/z values of the detected glycopeptides. H–hexose, NN-acetylhexosamine, F–fucose and S–N-acetylneuraminic acid (sialic acid). Blue square–N-acetylglucosamine (GlcNAc), green circle–mannose (Man), red triangle–fucose (Fuc), yellow circle–galactose (Gal), purple diamond–N-acetylneuraminic acid (Neu5Ac). The presence of MS/MS spectrum is indicated with +. N/D–not determined.

Identified N-200 glycopeptides on both prion strains.

Proposed glycan structures found on N-200 glycosylation site with the theoretical and observed m/z values of the detected glycopeptides. H–hexose, NN-acetylhexosamine, F–fucose and S–N-acetylneuraminic acid (sialic acid). Blue square–N-acetylglucosamine (GlcNAc), green circle–mannose (Man), red triangle–fucose (Fuc), yellow circle–galactose (Gal), purple diamond–N-acetylneuraminic acid (Neu5Ac). The presence of MS/MS spectrum is indicated with +. N/D–not determined.

Representation of detected glycoforms on the N-200 glycosylation site of 21K slow prion strain.

A) Extracted ion chromatograms with mutual 35 glycoforms detected. B) Assigned glycoforms in MS spectrum with N-200 peptide backbone: neutral and monosialylated, C) disialylated and trisialylated glycoforms. Blue square–N-acetylglucosamine (GlcNAc), green circle–mannose (Man), red triangle–fucose (Fuc), yellow circle–galactose (Gal), purple diamond–N-acetylneuraminic acid (Neu5Ac).
  1 in total

1.  Site-specific analysis of N-glycans from different sheep prion strains.

Authors:  Natali Nakić; Thanh Hoa Tran; Mislav Novokmet; Olivier Andreoletti; Gordan Lauc; Giuseppe Legname
Journal:  PLoS Pathog       Date:  2021-02-18       Impact factor: 6.823

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.